KLI

검색

Ulsan Univ. Repository

Browsing by Author : Byoung Chul Cho

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

or enter first few letters:

Sort by:
In order:
Results/Page
Etal:

Showing results 1 to 9 of 9

1 Article A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors Byoung Chul Cho ; Ji-Youn Han ; Sang-We Kim ; et al 2022
2 Article Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study 김상위 ; Amy Roshak ; Byoung Chul Cho ; et al 2021
3 Article Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer 이대호 ; Adnan Nagrial ; Byoung Chul Cho ; et al 2021
4 Article Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial 이대호 ; Byoung Chul Cho ; Chia-Chi Lin ; et al 2020
5 Article Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study 김상위 ; Anders Mellemgaard ; Byoung Chul Cho ; et al 2020
6 Article Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study 이대호 ; Aaron S Mansfield ; Benjamin Besse ; et al 2021
7 Article Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea 김상위 ; Bong-Seog Kim ; Byoung Chul Cho ; et al 2020
8 Article Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis 김상위 ; Byoung Chul Cho ; Cheol Hyeon Kim ; et al 2020
9 Article Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3) Morihito Okada ; Ken Kato ; Byoung Chul Cho ; et al 2022

OAK Ulsan Univ. Repository was built as a OAK to the National Central Library.